These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 18801385)

  • 1. Killer T cells in influenza.
    Stambas J; Guillonneau C; Kedzierska K; Mintern JD; Doherty PC; La Gruta NL
    Pharmacol Ther; 2008 Nov; 120(2):186-96. PubMed ID: 18801385
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cellular immune responses to influenza.
    Moss P
    Dev Biol (Basel); 2003; 115():31-7. PubMed ID: 15088773
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Induction of alphadelta- and alphabeta-mediated T cell responses in healthy elderly subjects after influenza vaccination.
    Re F; Donnini A; Provinciali M
    Biogerontology; 2006 Aug; 7(4):249-59. PubMed ID: 16821115
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunodominance in CD4 T-cell responses: implications for immune responses to influenza virus and for vaccine design.
    Sant AJ; Chaves FA; Krafcik FR; Lazarski CA; Menges P; Richards K; Weaver JM
    Expert Rev Vaccines; 2007 Jun; 6(3):357-68. PubMed ID: 17542751
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enhanced protective immunity against H5N1 influenza virus challenge by vaccination with DNA expressing a chimeric hemagglutinin in combination with an MHC class I-restricted epitope of nucleoprotein in mice.
    Tao P; Luo M; Pan R; Ling D; Zhou S; Tien P; Pan Z
    Antiviral Res; 2009 Mar; 81(3):253-60. PubMed ID: 19135483
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phenotypic changes in influenza-specific CD8+ T cells after immunization of children and adults with influenza vaccines.
    He XS; Holmes TH; Mahmood K; Kemble GW; Dekker CL; Arvin AM; Greenberg HB
    J Infect Dis; 2008 Mar; 197(6):803-11. PubMed ID: 18279048
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The novel adjuvant CoVaccineHT increases the immunogenicity of cell-culture derived influenza A/H5N1 vaccine and induces the maturation of murine and human dendritic cells in vitro.
    Bodewes R; Geelhoed-Mieras MM; Heldens JG; Glover J; Lambrecht BN; Fouchier RA; Osterhaus AD; Rimmelzwaan GF
    Vaccine; 2009 Nov; 27(49):6833-9. PubMed ID: 19772942
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Modelling pathways of CD8+ T-cell differentiation.
    Yates A
    Eur J Immunol; 2009 Jan; 39(1):47-9. PubMed ID: 19130546
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Narrowed TCR diversity for immunised mice challenged with recombinant influenza A-HIV Env(311-320) virus.
    Cukalac T; Moffat JM; Venturi V; Davenport MP; Doherty PC; Turner SJ; Stambas J
    Vaccine; 2009 Nov; 27(48):6755-61. PubMed ID: 19744584
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pandemic preparedness: toward a universal influenza vaccine.
    Roose K; Fiers W; Saelens X
    Drug News Perspect; 2009 Mar; 22(2):80-92. PubMed ID: 19330167
    [TBL] [Abstract][Full Text] [Related]  

  • 11. T cell mediated immunity to influenza: mechanisms of viral control.
    La Gruta NL; Turner SJ
    Trends Immunol; 2014 Aug; 35(8):396-402. PubMed ID: 25043801
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of HLA class II H5N1 hemagglutinin epitopes following subvirion influenza A (H5N1) vaccination.
    Zinckgraf JW; Sposato M; Zielinski V; Powell D; Treanor JJ; von Hofe E
    Vaccine; 2009 Aug; 27(39):5393-401. PubMed ID: 19596415
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mucosal immunity induced by adenovirus-based H5N1 HPAI vaccine confers protection against a lethal H5N2 avian influenza virus challenge.
    Park KS; Lee J; Ahn SS; Byun YH; Seong BL; Baek YH; Song MS; Choi YK; Na YJ; Hwang I; Sung YC; Lee CG
    Virology; 2009 Dec; 395(2):182-9. PubMed ID: 19836045
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Protective CD8 T cell memory is impaired during chronic CD70-driven costimulation.
    van Gisbergen KP; van Olffen RW; van Beek J; van der Sluijs KF; Arens R; Nolte MA; van Lier RA
    J Immunol; 2009 May; 182(9):5352-62. PubMed ID: 19380782
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antigen presentation and the regulation of CD4 memory generation to influenza.
    Jelley-Gibbs D; Haynes L; Swain S
    Expert Rev Clin Immunol; 2006 Jul; 2(4):601-11. PubMed ID: 20477616
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clonotype selection and composition of human CD8 T cells specific for persistent herpes viruses varies with differentiation but is stable over time.
    Iancu EM; Corthesy P; Baumgaertner P; Devevre E; Voelter V; Romero P; Speiser DE; Rufer N
    J Immunol; 2009 Jul; 183(1):319-31. PubMed ID: 19542443
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Estimating in vivo death rates of targets due to CD8 T-cell-mediated killing.
    Ganusov VV; De Boer RJ
    J Virol; 2008 Dec; 82(23):11749-57. PubMed ID: 18815293
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Blimp-1 transcription factor is required for the differentiation of effector CD8(+) T cells and memory responses.
    Kallies A; Xin A; Belz GT; Nutt SL
    Immunity; 2009 Aug; 31(2):283-95. PubMed ID: 19664942
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CD8(+) T cells specific for beta cells encounter their cognate antigens in the islets of NOD mice.
    Pang S; Zhang L; Wang H; Yi Z; Li L; Gao L; Zhao J; Tisch R; Katz JD; Wang B
    Eur J Immunol; 2009 Oct; 39(10):2716-24. PubMed ID: 19658094
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CD8+ T cells in type 1 diabetes.
    Tsai S; Shameli A; Santamaria P
    Adv Immunol; 2008; 100():79-124. PubMed ID: 19111164
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.